Mr. Ronald Ede is the Executive Director & Chief Financial Officer for Innovent Biologic Inc. Joined since 2017, Mr. Ede is responsible for finance, investor relations, fund, channel management and information technology of the Group.
Prior to joining the Group, from 2011 to 2016, Mr. Ede was the CFO of Biosensors International Ltd. From 2009 to 2011, he was the Executive Director and CFO of Mindray Medical International Limited. and from 2006 to May 2023, Mr. Ede was an independent non-Executive Director for Mindray Medical International Limited(a listed company on the Shenzhen Stock Exchange with stock code: 300760).
Mr. Ede is also an independent non-executive director for Dawnrays Pharmaceutical (Holding) Ltd. (a company listed on the Hong Kong Stock Exchange with stock code: 2348) since 2015.
Mr. Ede received his Bachelor of Business Administration degree from University of Hawaii in December 1984 and master of business administration degree from University of Washington in December 1988. Mr. Ede is a fellow member of the Institute of Singapore Chartered Accountants and an A-Share independent director certified by the Shenzhen Stock Exchange.